Investing

CapEx

McKesson CapEx increased by 2.8% to $111.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 34.3%, from $169.00M to $111.00M. Over 4 years (FY 2022 to FY 2026), CapEx shows an upward trend with a 3.0% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026

How to read this metric

An increase signals growth investment or infrastructure modernization; a decrease might suggest cost-cutting or a transition to an asset-light model.

Detailed definition

Funds used by a company to acquire, upgrade, and maintain physical assets such as property, plants, buildings, technolog...

Peer comparison

Hardware-focused tech firms typically have higher CapEx relative to revenue than pure software companies due to manufacturing and supply chain needs.

Metric ID: capital_expenditures

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$93.00M$93.00M$67.00M$135.00M$71.00M$86.00M$108.00M$125.00M$78.00M$75.00M$90.00M$188.00M$106.00M$136.00M$126.00M$169.00M$111.00M$106.00M$108.00M$111.00M
QoQ Change+0.0%-28.0%+101.5%-47.4%+21.1%+25.6%+15.7%-37.6%-3.8%+20.0%+108.9%-43.6%+28.3%-7.4%+34.1%-34.3%-4.5%+1.9%+2.8%
YoY Change-23.7%-7.5%+61.2%-7.4%+9.9%-12.8%-16.7%+50.4%+35.9%+81.3%+40.0%-10.1%+4.7%-22.1%-14.3%-34.3%
Range$67.00M$188.00M
CAGR+3.8%
Avg YoY Growth+8.4%
Median YoY Growth-7.5%
Current Streak2 quarters growth

Business Segments

View all
SegmentQ4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q2 '25
U.S. Pharmaceutical$38.50M$38.50M$48.25M$48.25M$48.25M$48.25M$28.00M$73.00M
Medical-Surgical Solutions$29.25M$29.25M$39.75M$39.75M$39.75M$39.75M$51.00M$25.00M
International$19.75M$19.75M$18.75M$18.75M$18.75M$18.75M$25.00M$13.00M
Prescription Technology Solutions$8.75M$7.75M$7.75M$7.75M$4.00M$1.00M
Total$108.00M$125.00M$78.00M$75.00M$90.00M$188.00M$106.00M$111.00M

International, Medical-Surgical Solutions, Prescription Technology Solutions, U.S. Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.

Frequently Asked Questions

What is McKesson's capex?
McKesson (MCK) reported capex of $111.00M in Q1 2026.
How has McKesson's capex changed year-over-year?
McKesson's capex decreased by 34.3% year-over-year, from $169.00M to $111.00M.
What is the long-term trend for McKesson's capex?
Over 4 years (2022 to 2026), McKesson's capex has grown at a 3.0% compound annual growth rate (CAGR), from $388.00M to $436.00M.
What does capex mean?
The money spent on long-term physical assets like machinery, data centers, and office buildings.